Compounds > cyproterone acetate
Page last updated: 2024-08-21

cyproterone acetate and Adenoma, Basal Cell

cyproterone acetate has been researched along with Adenoma, Basal Cell in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Elvira, R; Guijarro, G; Montoya, T; Olivar, J1
Chanson, P; Schaison, G1

Other Studies

2 other study(ies) available for cyproterone acetate and Adenoma, Basal Cell

ArticleYear
[Virilization of a post-menopausal woman. Diagnostic and therapeutic considerations].
    Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion, 2009, Volume: 56, Issue:8

    Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Aged; Androgens; Carcinoma, Transitional Cell; Cyproterone Acetate; Dexamethasone; Diagnosis, Differential; False Negative Reactions; Female; Gonadotropin-Releasing Hormone; Gonadotropins, Pituitary; Humans; Incidental Findings; Neoplasms, Second Primary; Ovarian Diseases; Postmenopause; Triptorelin Pamoate; Urinary Bladder Neoplasms; Virilism

2009
Pituitary apoplexy caused by GnRH-agonist treatment revealing gonadotroph adenoma.
    The Journal of clinical endocrinology and metabolism, 1995, Volume: 80, Issue:7

    Topics: Adenoma; Aged; Contrast Media; Cyproterone Acetate; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Organometallic Compounds; Pentetic Acid; Pituitary Apoplexy; Pituitary Neoplasms; Prostatic Neoplasms; Triptorelin Pamoate

1995